TG4010 and Nivolumab in Patients With Lung Cancer

NCT02823990 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Non-Small Cell Lung Carcinoma
Stage I Non-Small Cell Lung Cancer
Stage II Non-Small Cell Lung Cancer
Stage IIIA Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer
Stage IV Non-Small Cell Lung Cancer

Interventions

BIOLOGICAL: TG4010
BIOLOGICAL: Nivolumab

Sponsor

Megan Daly, MD

Collaborators

[object Object]
[object Object]
[object Object]